DrugPatentWatch Database Preview
Profile for Canada Patent: 2310097
US Patent Family Members and Approved Drugs for Canada Patent: 2310097
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Jan 7, 2018 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
➤ Try a Free Trial | Jan 7, 2018 | Astrazeneca Ab | BYDUREON PEN | exenatide synthetic |
➤ Try a Free Trial | Jan 7, 2018 | Astrazeneca Ab | BYETTA | exenatide synthetic |
➤ Try a Free Trial | Jan 7, 2018 | Astrazeneca Ab | BYDUREON BCISE | exenatide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |